Related Experiment Videos
[Experience with the Solcotrans orthopedic autotransfusion device in hip replacement surgery]
1Semmelweis Ortostudományi Egyetem, Ortopédiai Klinika.
Magyar Traumatologia, Orthopaedia Es Helyreallito Sebeszet
|January 1, 1991
Summary
Solcotrans Orthopaedic device use in hip surgery reduced homologous blood needs by 76% in 70% of patients. This safe, simple device is recommended for hip prosthetic surgery when infection or malignancy is absent.
Area of Science:
- Orthopaedic Surgery
- Transfusion Medicine
Context:
- Hip prosthetic surgery involves significant blood loss.
- Homologous blood transfusion carries risks and costs.
- Post-operative blood salvage offers a potential solution.
Purpose:
- To evaluate the efficacy and safety of the Solcotrans Orthopaedic device for autologous blood reinfusion in hip prosthetic surgery.
- To assess the impact of the device on homologous blood usage.
Summary:
- A study involving 20 patients undergoing hip prosthetic surgery utilized the Solcotrans Orthopaedic device for post-operative blood salvage and reinfusion.
- 70% of patients avoided the need for additional homologous blood, resulting in a 76% reduction in overall homologous blood consumption.
- No clinically significant adverse effects were observed, indicating the device's safety and ease of use.
Impact:
- The Solcotrans Orthopaedic device demonstrates significant potential to reduce homologous blood transfusion requirements in hip prosthetic surgery.
- This can lead to decreased healthcare costs and improved patient outcomes by minimizing transfusion-related risks.
- The study recommends the device for eligible patients, excluding those with joint infection or malignancy.